BioSpace News Archive

Job Trends

Press Release: European Commission grants first approval worldwide of Beyfortus® (nirsevimab) for prevention of RSV disease in infants

The European Commission has approved Beyfortus® for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants during their first RSV season.

November 4, 2022
·
14 min read
Business

Amneal Reports Third Quarter 2022 Financial Results

Amneal Pharmaceuticals, Inc. announced its results for the third quarter ended September 30, 2022.

November 4, 2022
·
12 min read
Bio NC

Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine

Pfizer Inc. and BioNTech SE announced updated data from a Phase 2/3 clinical trial demonstrating a robust neutralizing immune response one-month after a 30-µg booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine.

November 4, 2022
·
25 min read
Bio NC

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 04, 2022

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted 14 newly-hired employees stock options to purchase an aggregate of 125,700 shares, and restricted stock units covering an aggregate of 46,350 shares, of BioCryst common stock.

November 4, 2022
·
1 min read
Business

Cardinal Health Reports First Quarter Fiscal 2023 Results

Cardinal Health reported first quarter fiscal year 2023 revenues of $49.6 billion, an increase of 13% from the first quarter of last year.

November 4, 2022
·
23 min read
Business

Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022

Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today reported recent company updates and financial results for its fiscal second quarter ended September 30, 2022.

November 4, 2022
·
10 min read
Business

Medicenna Reports Second Quarter Fiscal 2023 Financial Results and Operational Highlights

Medicenna today announced its financial results and operational highlights for the quarter ended September 30, 2022. All dollar amounts are in Canadian currency unless otherwise noted.

November 4, 2022
·
12 min read
Bio NC

RedHill Presents New Talicia® Data Analyses at Obesity Week 2022

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced the presentation of new Talicia® data analyses for the treatment of H. pylori, at the Obesity Week Annual Meeting, November 1-4, 2022.

November 4, 2022
·
14 min read
Sernova to Participate in the Stifel Healthcare 2022 Conference

Sernova Corp., a clinical-stage company and leader in cell therapeutics, announced it will be presenting at the upcoming Stifel Healthcare Conference being held in-person in New York, NY on November 15-16, 2022.

November 4, 2022
·
4 min read
Genetown

Xilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’ Summit

Xilio Therapeutics, Inc. today announced that the company will participate in a virtual fireside chat at the Cowen 6th Annual IO Next Summit on Friday, November 11, 2022, at 1:40 p.m. ET.

November 4, 2022
·
1 min read